N-(2-aminophenyl)pyrazine-2-carboxamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View N-(2-aminophenyl)pyrazine-2-carboxamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
N-(2-aminophenyl)pyrazine-2-carboxamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	KRT5 Gene (Entity type)	-0.015218188
BG-1022 Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	N-(2-aminophenyl)pyrazine-2-carboxamide Compound (Entity type)	0.41140016913414
N-(2-aminophenyl)pyrazine-2-carboxamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	PPIF Gene (Entity type)	-0.014647085
N-(2-aminophenyl)pyrazine-2-carboxamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	IL20RA Gene (Entity type)	-0.014390499
N-(2-aminophenyl)pyrazine-2-carboxamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	AUTS2 Gene (Entity type)	-0.016171955
N-(2-aminophenyl)pyrazine-2-carboxamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	FABP5 Gene (Entity type)	0.023252895
BML-210 Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	N-(2-aminophenyl)pyrazine-2-carboxamide Compound (Entity type)	0.6200123429298401
N-(2-aminophenyl)pyrazine-2-carboxamide Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	BML-210 Compound (Entity type)	0.6200123429298401
N-(2-aminophenyl)pyrazine-2-carboxamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	ATP6V1D Gene (Entity type)	-0.017417101
N-(2-aminophenyl)pyrazine-2-carboxamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	STAR Gene (Entity type)	-0.02102544

N-(2-aminophenyl)pyrazine-2-carboxamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
KRT5
Gene (Entity type)
-0.015218188

BG-1022
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
N-(2-aminophenyl)pyrazine-2-carboxamide
Compound (Entity type)
0.41140016913414

N-(2-aminophenyl)pyrazine-2-carboxamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
PPIF
Gene (Entity type)
-0.014647085

N-(2-aminophenyl)pyrazine-2-carboxamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
IL20RA
Gene (Entity type)
-0.014390499

N-(2-aminophenyl)pyrazine-2-carboxamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
AUTS2
Gene (Entity type)
-0.016171955

N-(2-aminophenyl)pyrazine-2-carboxamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
FABP5
Gene (Entity type)
0.023252895

BML-210
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
N-(2-aminophenyl)pyrazine-2-carboxamide
Compound (Entity type)
0.6200123429298401

N-(2-aminophenyl)pyrazine-2-carboxamide
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
BML-210
Compound (Entity type)
0.6200123429298401

N-(2-aminophenyl)pyrazine-2-carboxamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
ATP6V1D
Gene (Entity type)
-0.017417101

N-(2-aminophenyl)pyrazine-2-carboxamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
STAR
Gene (Entity type)
-0.02102544

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.